SV2008003053A - Utilizacion de un compuesto anti-aterotrombotico para la obtencion de medicamentos destinados al tratamiento de los trastornos vasculares - Google Patents
Utilizacion de un compuesto anti-aterotrombotico para la obtencion de medicamentos destinados al tratamiento de los trastornos vascularesInfo
- Publication number
- SV2008003053A SV2008003053A SV2008003053A SV2008003053A SV2008003053A SV 2008003053 A SV2008003053 A SV 2008003053A SV 2008003053 A SV2008003053 A SV 2008003053A SV 2008003053 A SV2008003053 A SV 2008003053A SV 2008003053 A SV2008003053 A SV 2008003053A
- Authority
- SV
- El Salvador
- Prior art keywords
- obtaining
- treatment
- medicines
- vascular disorders
- aterotrombotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A LA UTILIZACIÓN DE UN ANTAGONISTA ESPECÍFICO DE LOS RECEPTORES TP PARA LA OBTENCIÓN DE MEDICAMENTOS DESTINADOS AL TRATAMIENTO DE LOS TRASTORNOS VASCULARES EN EL PACIENTE QUE PRESENTA UN ANTECEDENTE DE ACCIDENTE VASCULAR CEREBRAL, ESPECIALMENTE PARA LA REDUCCIÓN DE LOS SUCESOS CEREBRO-VASCULARES Y CARDIOVASCULARES EN LOS PACIENTES QUE PRESENTAN UN ANTECEDENTE DE ACCIDENTE ISQUÉMICO CEREBRAL (AIC) O DE ATAQUE ISQUÉMICO TRANSITORIO (AIT)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0603082A FR2899473B1 (fr) | 2006-04-07 | 2006-04-07 | Utilisation d'un compose anti-atherothrombotique pour l'obtention de medicaments destines au traitement des troubles vasculaires |
Publications (1)
Publication Number | Publication Date |
---|---|
SV2008003053A true SV2008003053A (es) | 2009-12-02 |
Family
ID=37084627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV2008003053A SV2008003053A (es) | 2006-04-07 | 2008-10-02 | Utilizacion de un compuesto anti-aterotrombotico para la obtencion de medicamentos destinados al tratamiento de los trastornos vasculares |
Country Status (40)
Country | Link |
---|---|
US (1) | US20070238785A1 (es) |
EP (2) | EP2105132A1 (es) |
JP (1) | JP2009532447A (es) |
KR (2) | KR20070100658A (es) |
CN (2) | CN101693025A (es) |
AP (1) | AP2007003952A0 (es) |
AR (1) | AR060288A1 (es) |
AT (1) | ATE452633T1 (es) |
AU (1) | AU2007201525A1 (es) |
BR (1) | BRPI0701597A (es) |
CA (1) | CA2582394A1 (es) |
CO (1) | CO5820217A1 (es) |
CR (1) | CR9020A (es) |
CY (1) | CY1109793T1 (es) |
DE (1) | DE602007003880D1 (es) |
DK (1) | DK1842537T3 (es) |
EA (1) | EA013874B1 (es) |
ES (1) | ES2338600T3 (es) |
FR (1) | FR2899473B1 (es) |
GE (1) | GEP20094782B (es) |
GT (1) | GT200700029A (es) |
HR (1) | HRP20100091T1 (es) |
IL (1) | IL182406A0 (es) |
MA (1) | MA28988B1 (es) |
MX (1) | MX2007004108A (es) |
NI (1) | NI200700083A (es) |
NO (1) | NO20071833L (es) |
NZ (1) | NZ554348A (es) |
PE (1) | PE20071147A1 (es) |
PL (1) | PL1842537T3 (es) |
PT (1) | PT1842537E (es) |
RS (1) | RS51207B (es) |
SG (1) | SG136882A1 (es) |
SI (1) | SI1842537T1 (es) |
SV (1) | SV2008003053A (es) |
TN (1) | TNSN07117A1 (es) |
TW (1) | TW200808306A (es) |
UY (1) | UY30263A1 (es) |
WO (1) | WO2007116138A1 (es) |
ZA (1) | ZA200702866B (es) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9102862D0 (en) * | 1991-02-11 | 1991-03-27 | Erba Carlo Spa | N-imidazolyl derivatives of substituted or alkoxymino tetrahydronaphthalenes and chromans |
RU2120292C1 (ru) * | 1992-07-22 | 1998-10-20 | Российско-германское акционерное общество закрытого типа "УТИЛЕКС" | Способ лечения мозговых сосудистых кризов |
FR2711139B1 (fr) * | 1993-10-15 | 1995-12-01 | Adir | Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
DE4343776A1 (de) * | 1993-12-17 | 1995-06-22 | Schering Ag | Cyclopentanonderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
JPH08119936A (ja) * | 1994-10-18 | 1996-05-14 | Fujisawa Pharmaceut Co Ltd | 複素環式誘導体 |
FR2805261A1 (fr) * | 2000-02-18 | 2001-08-24 | Adir | Nouveaux derives d'acides 6-amino ou 6-hydrazinosulfonyl-3- quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2857593B1 (fr) * | 2003-07-18 | 2005-10-14 | Servier Lab | Composition pharmaceutique orodispersible d'un compose antithrombotique |
FR2860436B1 (fr) * | 2003-10-03 | 2006-01-20 | Servier Lab | Nouvelle association d'un anti-atherothrombotique et d'un antiagregant plaquettaire |
-
2006
- 2006-04-07 FR FR0603082A patent/FR2899473B1/fr not_active Expired - Fee Related
-
2007
- 2007-03-26 PE PE2007000339A patent/PE20071147A1/es not_active Application Discontinuation
- 2007-03-26 AP AP2007003952A patent/AP2007003952A0/xx unknown
- 2007-03-27 CA CA002582394A patent/CA2582394A1/fr not_active Abandoned
- 2007-03-28 GT GT200700029A patent/GT200700029A/es unknown
- 2007-03-28 TN TNP2007000117A patent/TNSN07117A1/fr unknown
- 2007-03-28 CR CR9020A patent/CR9020A/es not_active Application Discontinuation
- 2007-03-29 NI NI200700083A patent/NI200700083A/es unknown
- 2007-04-03 CO CO07033656A patent/CO5820217A1/es not_active Application Discontinuation
- 2007-04-03 MA MA29799A patent/MA28988B1/fr unknown
- 2007-04-04 MX MX2007004108A patent/MX2007004108A/es not_active Application Discontinuation
- 2007-04-04 TW TW096112170A patent/TW200808306A/zh unknown
- 2007-04-04 AR ARP070101419A patent/AR060288A1/es unknown
- 2007-04-05 NZ NZ554348A patent/NZ554348A/en unknown
- 2007-04-05 AU AU2007201525A patent/AU2007201525A1/en not_active Abandoned
- 2007-04-05 BR BRPI0701597-6A patent/BRPI0701597A/pt not_active IP Right Cessation
- 2007-04-05 ZA ZA200702866A patent/ZA200702866B/xx unknown
- 2007-04-05 GE GEAP20079967A patent/GEP20094782B/en unknown
- 2007-04-05 US US11/784,070 patent/US20070238785A1/en not_active Abandoned
- 2007-04-05 SG SG200702553-9A patent/SG136882A1/en unknown
- 2007-04-06 ES ES07290421T patent/ES2338600T3/es active Active
- 2007-04-06 EA EA200700573A patent/EA013874B1/ru not_active IP Right Cessation
- 2007-04-06 PL PL07290421T patent/PL1842537T3/pl unknown
- 2007-04-06 DK DK07290421.2T patent/DK1842537T3/da active
- 2007-04-06 DE DE602007003880T patent/DE602007003880D1/de active Active
- 2007-04-06 EP EP09163685A patent/EP2105132A1/fr not_active Withdrawn
- 2007-04-06 RS RSP-2010/0111A patent/RS51207B/sr unknown
- 2007-04-06 CN CN200910205034A patent/CN101693025A/zh active Pending
- 2007-04-06 AT AT07290421T patent/ATE452633T1/de active
- 2007-04-06 WO PCT/FR2007/000588 patent/WO2007116138A1/fr active Application Filing
- 2007-04-06 EP EP07290421A patent/EP1842537B1/fr active Active
- 2007-04-06 SI SI200730154T patent/SI1842537T1/sl unknown
- 2007-04-06 PT PT07290421T patent/PT1842537E/pt unknown
- 2007-04-06 CN CNA2007100910717A patent/CN101049292A/zh active Pending
- 2007-04-06 KR KR1020070034004A patent/KR20070100658A/ko active Search and Examination
- 2007-04-06 JP JP2009503618A patent/JP2009532447A/ja active Pending
- 2007-04-09 UY UY30263A patent/UY30263A1/es not_active Application Discontinuation
- 2007-04-10 NO NO20071833A patent/NO20071833L/no not_active Application Discontinuation
- 2007-04-10 IL IL182406A patent/IL182406A0/en unknown
-
2008
- 2008-10-02 SV SV2008003053A patent/SV2008003053A/es unknown
-
2009
- 2009-07-22 KR KR1020090066778A patent/KR20090086500A/ko not_active Application Discontinuation
-
2010
- 2010-02-05 CY CY20101100118T patent/CY1109793T1/el unknown
- 2010-02-19 HR HR20100091T patent/HRP20100091T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014000380A2 (pt) | composição farmacêutica, métodos para tratamento e usos dos mesmos | |
EA202091999A3 (ru) | Применение ингибиторов dpp iv | |
BRPI0707712B8 (pt) | aparelho para conter uma placa óssea, placa óssea e instrumentação para fixação óssea | |
GT201000182A (es) | Regimen de dosificacion asociado con ésteres de paliperidona inyectables de acción prolongada | |
BRPI0609393B8 (pt) | usos de um composto 11-desóxi-prostaglandina | |
BR112014008789A2 (pt) | prevenção e tratamento de condições oculares | |
MX2009002921A (es) | Derivados de azetidinona para el tratamiento de trastornos del metabolismo lipidico. | |
CL2011003347A1 (es) | Composicion farmaceutica que comprende un conjugado, correspondiente a benzoato de hidrocodona ; y uso en el tratamiento de una enfermedad, trastorno o afeccion mediada por la union de un opioide a receptores opioides. | |
GT201100118A (es) | Compuestos de arilo con sustituyentes heterocíclicos como inhibidores hif | |
MX2013004699A (es) | Combinaciones farmaceuticas para el tratamiento de trastornos metabolicos. | |
BR112014008666A8 (pt) | acelerando recuperação de músculo após a atrofia muscular ter induzido imobilização | |
TW200740452A (en) | Therapeutic gastrodia extracts | |
BRPI0713447A2 (pt) | composição forma de dosagem oral sólida, e, método para o tratamento de dor | |
HU0800434D0 (en) | Template to determine the places of the injections, especially for regular medicament injection and/or blood testing | |
BR112012022552A2 (pt) | uso de fenoterol e de anélogos de fenoterol no tratamento de gliobastomas e astrocitomas | |
BRPI0917992A2 (pt) | dispositivo para causar uma liberação de uma cola cirúrgica em uma região de operação no corpo de um paciente para bloquear um fluxo de sangue de uma artéria. | |
BR112015015108A2 (pt) | cateter com marcações para facilitar o alinhamento | |
BR112016028446A2 (pt) | inibidor de complemento de ornithodoros moubata para uso no tratamento de doenças mediadas por complemento em pacientes com polimorfismo de c5 | |
WO2009099553A3 (en) | Use of kinase inhibitor in treatment of atherosclerosis | |
BR112014020113A8 (pt) | Composições farmacêuticas e método para diminuir a frequência de micção | |
IN2015DN01975A (es) | ||
BR112013031431A2 (pt) | método para o diagnóstico da doença de gaucher | |
SV2008003053A (es) | Utilizacion de un compuesto anti-aterotrombotico para la obtencion de medicamentos destinados al tratamiento de los trastornos vasculares | |
BR112012028153A2 (pt) | composição farmacêutica e método para o tratamento de hipertensão | |
EP2220057A4 (en) | PROSTAGLANDIN E1 AND E2 ANALOGUES FOR THE TREATMENT OF VARIOUS MEDICAL CONDITIONS |